Onesource Specialty Pharma Schedules Earnings Call for Q1FY27 Results Discussion
Onesource Specialty Pharma Ltd has scheduled an earnings call inviting analysts and investors to discuss the unaudited financial results for the first quarter of fiscal year 2027 (Q1FY27), which ended on June 30, 2026.The earnings interaction is set for Saturday, July 25, 2026, commencing at 10:00 AM IST. The company's senior management team will be present to interact with participants regarding the quarterly performance.
Neeraj Sharma, CEO & MD, and Anurag Bhagania, CFO are slated to speak during the conference call.
Details for participation in the earnings call have been released for interested parties, allowing them to join the discussion regarding the company's financial results for the quarter ended June 30, 2026.
The following details provide access information for the conference call:
| Access Type | Details |
|---|---|
| Universal Access (for conference call) | +91 22 6280 1372, +91 22 7115 8193 |
| DiamondPass Registration | A specific registration link was provided for early access. |
The company has organized this session to discuss the unaudited financial results with its investor community and analysts.
ONESOURCE Stock Price Movement
As of 12:27 PM, Shares of Onesource Specialty Pharma Limited are shedding value in live trading, slipping by 2.47% to trade at ₹1652.10. The stock has seen substantial activity this morning alone, with a volume of 105,619 shares recorded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.